In a report released on October 3, Joanne Wuensch from Citi maintained a Buy rating on Glaukos, with a price target of $110.00. The company’s shares closed yesterday at $86.62.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Wuensch is a 4-star analyst with an average return of 6.0% and a 60.90% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Medtronic, Tandem Diabetes Care, and Dexcom.
Currently, the analyst consensus on Glaukos is a Strong Buy with an average price target of $117.08, implying a 35.17% upside from current levels. In a report released on October 1, Goldman Sachs also initiated coverage with a Buy rating on the stock with a $103.00 price target.
GKOS market cap is currently $4.97B and has a P/E ratio of -52.27.
Read More on GKOS:
/Semiconductor%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
